肝脏 ›› 2021, Vol. 26 ›› Issue (8): 899-902.

• 其他肝病 • 上一篇    下一篇

肝介入栓塞与开腹手术治疗Ⅲ、Ⅳ级肝外伤后肝功能恢复情况比较

陈俊, 田甜, 江慧珍, 许望   

  1. 571300 海南 文昌市人民医院放射科(陈俊,田甜,江慧珍);海南省人民医院检验科(许望)
  • 收稿日期:2021-03-28 出版日期:2021-08-31 发布日期:2021-09-29
  • 基金资助:
    海南省自然科学基金面上项目[817362]

A comparison of liver function recovery between interventional embolization and open abdominal surgery for the treatment of grades III and IV liver trauma

CHEN Jun1, TIAN tian1, JIANG Hui-zhen1, XU Wang2   

  1. 1. Department of Radiology,Wenchang City People's Hospital,Wenchang 571300,Hainan Province,China;
    2. Laboratory of Hainan Provincial People's Hospital Haikou 570311
  • Received:2021-03-28 Online:2021-08-31 Published:2021-09-29

摘要: 目的 探讨肝介入栓塞术和开腹手术治疗Ⅲ、Ⅳ级肝外伤患者对术后肝功能的影响。方法 文昌市人民医院2017年5月至2020年11月收治82例Ⅲ、Ⅳ级肝外伤患者,根据手术治疗方案不同分为观察组(40例,行肝介入栓塞术)和对照组(42例,行开腹手术)。比较两组术后恢复效果,记录术后肝功能状态和术后并发症发生情况。结果 观察组无死亡病例,对照组死亡2例。观察组患者手术时间和术后住院时间分别为(69.3±13.1)min和(7.6±1.3)d,短于对照组的(114.7±20.2)min和(9.2±1.8)d(t=12.010、4.595,P<0.05)。观察组术中出血量为(165.0±45.8)mL,少于对照组(214.9±70.3)mL(t=3.788,P<0.05)。术后1 d时观察组AST、ALT、总胆红素(TBil)及谷氨酰转肽酶(GGT)分别为(237.5±80.2)U/L、(298.7±98.5)U/L、(94.2±27.2)μmol/L及(103.2±21.4)U/L,低于对照组的(280.2±69.6)U/L、(367.7±86.1)U/L、(117.3±20.2)μmol/L及(118.9±26.4)U/L(t=2.543、3.336、4.312、2.922,P<0.05)。术后3 d时观察组AST、ALT、TBil及GGT分别为(104.4±54.3)U/L、(175.5±80.3)U/L、(64.4±19.5)μmol/L及(90.6±16.3)U/L,低于对照组的(173.5±70.3)U/L、(245.8±98.5)U/L、(82.2±15.3)μmol/L及(107.7±26.3)U/L(t=4.920、3.499、4.542、3.495,P<0.05)。术后5 d时观察组AST、ALT、TBil及GGT分别为(90.6±36.5)U/L,(105.4±96.5)U/L,(57.9±17.6)μmol/L及(80.5±13.7)U/L,低于对照组的(138.2±33.6)U/L、(182.3±63.2)U/L、(75.7±20.1)μmol/L及(95.1±18.8)U/L(t=6.068、4.216、4.214、3.969,P<0.05)。观察组术后腹腔出血1例,对照组腹腔出血7例,肝脓肿5例,两组术后腹腔出血和肝脓肿发生率比较,差异有统计学意义(χ2=5.000,5.333;P<0.05)。结论 与开腹手术相比,肝介入栓塞治疗Ⅲ、Ⅳ级肝外伤效果可靠,安全性高,有助于术后肝功能早期恢复。

关键词: 肝介入栓塞术, 开腹手术, Ⅲ、Ⅳ级肝外伤, 肝功能

Abstract: Objective To study on the recovery of liver function in patients with grades III and IV liver trauma after interventional embolization or open abdominal surgical therapies.Methods 82 patients with grades III and IV liver trauma from May 2017 to November 2020 were included. They were divided into an observation group (40 cases, treated with hepatic interventional embolization) and a control group (42 cases, treated with laparotomy) according to different treatments that the patients had received. The postoperative liver function and complications were recorded in all patients, and the postoperative recovery was compared between the two groups.Results No death in the observation group but 2 cases of death in the control group happened after the treatments. The operation time and postoperative hospital stay of the observation group were significantly shorter than those of the control group (69.3±13.1 min vs 114.7±20.2 min, and 7.6±1.3 d vs 9.2±1.8 d, respectively)(t=12.010, 4.595; P<0.05). The amount of bleeding in the observation group was significantly less than that of the control group (165.0±45.8 mL vs 214.9±70.3 mL, t=3.788, P<0.05). The levels of aspartate aminotransferase (AST), alanine aminotransferase (ALT), total bilirubin (TBil) and gamma glutamyl transferase (GGT) in patients of the observation group were significantly lower than those in the control group at one day (237.5±80.2 U/L, 298.7±98.5 U/L, 94.2±27.2 μmol/L and 103.2±21.4 U/L vs 280.2±69.6 U/L, 367.7±86.1 U/L, 117.3±20.2 μmol/L and 118.9±26.4 U/L; t=2.543, 3.336, 4.312 and 2.922, respectively; P<0.05), 3 days (104.4±54.3 U/L, 175.5±80.3U/L, 64.4±19.5 μmol/L and 90.6±16.3 U/L, vs 173.5±70.3 U/L, 245.8±98.5 U/L, 82.2±15.3 μmol/L and 107.7±26.3 U/L, t=4.920, 3.499, 4.542, and 3.495, respectively; P<0.05) and 5 days (90.6±36.5 U/L, 105.4±96.5 U/L, 57.9±17.6 μmol/L and 80.5±13.7 U/L, vs 138.2±33.6 U/L, 182.3±63.2 U/L, 75.7±20.1 μmol/L and 95.1±18.8 U/L, t=6.068, 4.216, 4.214, 3.969, respectively; P<0.05) after operation. There were significant differences in the incidence of postoperative abdominal bleeding (1 case vs 7 cases) and liver abscess (0 case vs 5 cases) between the observation group and the control group (χ2=5.000 and 5.333, respectively; P<0.05).Conclusion The transcatheter hepatic embolization therapy is effective and safe for the treatment of grades III and IV liver trauma. The early recovery of liver function after embolization therapy is better than that of open abdominal surgery.

Key words: Hepatic interventional embolization, Laparotomy, Grades III and IV hepatic trauma, Hepatic function